Roy Matkovic is studying epigenetic repression of HIV. After the virus integrates in the host genome, it can be inactive for a long time, and Matkovic, a molecular virologist at Institut Cochin in ...
Equillium’s phase 3 graft-versus-host disease (GVHD) trial has missed its primary endpoint and two key secondary objectives.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback